Cite
Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial.
MLA
Macoveanu, Julian, et al. “Effects of Erythropoietin on Cognitive Impairment and Prefrontal Cortex Activity across Affective Disorders: A Randomized, Double-Blinded, Placebo-Controlled Trial.” Journal of Psychopharmacology, vol. 38, no. 4, Apr. 2024, pp. 362–74. EBSCOhost, https://doi.org/10.1177/02698811241237869.
APA
Macoveanu, J., Petersen, J. Z., Mariegaard, J., Jespersen, A. E., Cramer, K., Bruun, C. F., Madsen, H. Ø., Jørgensen, M. B., Vinberg, M., Fisher, P. M., Knudsen, G. M., Hageman, I., Ehrenreich, H., Kessing, L. V., & Miskowiak, K. W. (2024). Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial. Journal of Psychopharmacology, 38(4), 362–374. https://doi.org/10.1177/02698811241237869
Chicago
Macoveanu, Julian, Jeff Zarp Petersen, Johanna Mariegaard, Andreas Elleby Jespersen, Katrine Cramer, Caroline Fussing Bruun, Helle Østergaard Madsen, et al. 2024. “Effects of Erythropoietin on Cognitive Impairment and Prefrontal Cortex Activity across Affective Disorders: A Randomized, Double-Blinded, Placebo-Controlled Trial.” Journal of Psychopharmacology 38 (4): 362–74. doi:10.1177/02698811241237869.